Overall (N = 20) | Single therapy (N = 11) | Combination therapy (N = 9) | P value | |
---|---|---|---|---|
Patients characteristics | ||||
Men (n, %) | 10 (50.0%) | 6 (54.5%) | 4 (44.4%) | 1.00 |
Age (year), (median [IQR]) | 60.0 [47.5;69.2] | 60.0 [52.0;74.0] | 57.0 [46.0;67.0] | 0.27 |
BMI (kg/m2), (median [IQR]) | 26.0 [23.2;27.7] | 26.1 [23.3;29.3] | 25.3 [23.0;26.4] | 0.69 |
eGFR (ml/min/1.73m2) (median [IQR]) | 94.5 [78.5;111] | 95.0 [71.5;114] | 91.0 [84.0;109] | 0.76 |
Charlson comorbidity index (with age) (median [IQR]) | 2.00 [0.75;4.25] | 4.00 [0.50;6.50] | 2.00 [1.00;2.00] | 0.17 |
Primary surgery characteristics | ||||
Number of previous spinal surgery (median [IQR]) | 1.00 [1.00;1.00] | 1.00 [1.00;1.00] | 1.00 [1.00;1.00] | 0.67 |
Surgical indication (n, %) | ||||
Degenerative spine disease | 19 (95.0%) | 10 (90.9%) | 9 (100%) | 1.00 |
Vertebral metastasis | 1 (5.00%) | 1 (9.09%) | 0 (0.00%) | |
Laminectomy (n, %) | 20 (100%) | 11 (100%) | 9 (100%) | |
Spinal implants (n, %) | 2 (10.0%) | 2 (18.2%) | 0 (0.00%) | |
Extent of surgery (number of vertebrae involved) (median [IQR]) | 3.00 [2.00;4.00] | 4.00 [2.50;4.50] | 2.00 [2.00;3.00] | 0.05 |
Initial ASA score (median [IQR]) | 2.00 [1.00;3.00] | 2.00 [1.50;3.00] | 1.00 [1.00;2.00] | 0.20 |
Post-surgical spinal infection | ||||
Delay between first surgery and revision surgery (days) (median [IQR]) | 22.5 [17.8;29.8] | 23.0 [19.5;32.0] | 22.0 [17.0;24.0] | 0.45 |
Local signs of infection (n, %) | 20 (100%) | 11 (100%) | 9 (100%) | 1.00 |
Fever (n, %) | 6 (30.0%) | 4 (36.4%) | 2 (22.2%) | 0.64 |
Site of involvement (n, %) | 0.22 | |||
Cervical spine | 4 (20%) | 3 (27.3%) | 1 (11.1%) | |
Thoracic spine | 1 (5%) | 1 (9.09%) | 0 (0%) | |
Lumbar spine | 14 (70%) | 7 (63.6%) | 7 (77.8%) | |
Sacral spine | 3 (15%) | 0 (0%) | 3 (33.3%) | |
Number of vertebrae involved (median [IQR]) | 2.50 [2.00;4.00] | 4.00 [2.00;4.00] | 2.00 [2.00;3.00] | 0.13 |
Blood cultures performed (n, %) | 4 (20%) | 3 (27%) | 1 (11%) | 0.59 |
Positive blood culture, (n, %) | 0 | 0 | 0 | |
Positive surgical cultures if surgery performed (n, %) | 20 (100%) | 11 (100%) | 9 (100%) | 1.00 |
Implant removal (n, %) | 2 (10.0%) | 2 (18.2%) | 0 (0.00%) | |
Staphylococcus aureus (n, %) | 16 (80.0%) | 9 (81.8%) | 7 (77.8%) | 1.00 |
Wild type* (n, %) | 4 (25.0%) | 3 (33.0%) | 1 (14.0%) | |
methicillin susceptible (n, %) | 16 (100%) | 9 (100%) | 7 (100%) | |
fluoroquinolone resistant (n, %) | 0 | 0 | 0 | |
rifampicin resistant (n, %) | 0 | 0 | 0 | |
Coagulase negative staphylococci (%) | 4 (20.0%) | 2 (18.2%) | 2 (22.2%) | 1.00 |
methicillin susceptible (n, %) | 2 (50%) | 1 (50%) | 1 (50%) | |
methicillin resistant (n, %) | 2 (50%) | 1 (50%) | 1 (50%) | |
fluoroquinolone resistant (n, %) | 2 (50%) | 1 (50%) | 1 (50%) | |
rifampicin resistant (n, %) | 0 | 0 | 0 |